Eli Lilly (LLY) Q3 2026 Earnings Call Transcript
On its third-quarter 2026 earnings call, Eli Lilly reported revenue growth of 39%, attributed to demand for its obesity drugs and strong international growth.
fool.com ·
支援資產
開啟 Mo
禮來
盤前
US$1,424.48
-所選期間
+US$15.09 (+1.07%)相較美股收盤
新聞
Eli Lilly 'Deserves' Stock Upside: Analyst
Benzinga reports Eli Lilly beat third-quarter estimates on Mounjaro and Zepbound growth, with 2026 revenue guidance rising to $92 billion.
benzinga.com ·
LLY股價創歷史新高，執行長表示中等收入消費者正推動製藥業「史上最大新品類擴張」
禮來執行長大衛·瑞克斯表示，中等收入消費者正在推動他所稱製藥業「最大規模的新品類擴張」，此說法出自Benzinga對該公司最新財報的報導。
benzinga.com ·
Eli Lilly raised its outlook for a third time this year thanks to soaring Zepbound sales
Eli Lilly raised its revenue guidance to $91 billion to $92 billion from $85 billion to $87 billion, its third outlook increase this year, as quarterly sales climbed 39%.
qz.com ·
Eli Lilly in Charts: Q3 Mounjaro reaches $10.7B, Jardiance surges 64.5% Y/Y to $1.58B
Seeking Alpha reports Mounjaro sales reached $10.7B in the third quarter, while Jardiance rose 64.5% year over year to $1.58B.
seekingalpha.com ·
代幣
- 代幣
- LLYc
- 每枚代幣對應股數
- 1.00000000 LLY
取得 Mo
在 Mo 中持有
將 LLYc 存放在你自行掌控的 Base 上 Mo 智慧錢包中。
快速轉移
免費將 LLYc 發送給其他 Mo 使用者，或以極快速度轉移至任何相容的 Base 錢包。